BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2014
View Archived Issues
U.S. and U.K. affiliation to support early-stage drug discovery and development
Read More
New Oncology to collaborate with National Cancer Centre Singapore on NEO platform
Read More
Asuragen launches Quantidex DNA Assay
Read More
NIAID contract supports Integral Molecular's work on Ebola and HCV antibody response
Read More
Affiris plans pilot studies of vaccines for Parkinson's disease and multiple system atrophy
Read More
Fundacion MEDINA discloses new antifungal compounds
Read More
First patient dosed in phase II trial of aramchol for the treatment of cholesterol gallstones
Read More
Roche patents novel CB2 receptor agonists
Read More
New DLK inhibitors designed at Roche and Genentech
Read More
Sunshine Lake Pharma patents novel aminoquinazoline derivatives
Read More
Nerviano Medical Sciences discloses novel antitumor anthracyclines
Read More
INV-17 demonstrates safety and therapeutic activity in a model of rheumatoid arthritis
Read More
Non-propagating dengue vaccine induces neonatal immunity in mice
Read More
Phase II results for the HBV and HDV entry inhibitor Myrcludex B
Read More
Insulin sparing activity of adenoviral protein E4orf1 may be beneficial for insulin resistance
Read More
Cytomedix changes name to Nuo Therapeutics
Read More
RGFP-966, an epigenetic HDAC3 inhibitor, tested in a rat cocaine-abuse model
Read More
Alnylam reports phase II results for transthyretin-targeting RNAi in cardiac amyloidosis
Read More
Merck KGaA and Pfizer establish global strategic alliance in immuno-oncology
Read More
Genticel completes enrollment in phase II HPV trial of ProCervix
Read More
Roche returns rights for INO-5150 to Inovio, maintains INO-1800 collaboration
Read More
Puma Biotechnology discloses results from phase II study comparing neratinib and trastuzumab
Read More
FDA approves Genzyme's Lemtrada for relapsing MS
Read More
FDA approves Avastin for platinum-resistant recurrent ovarian cancer
Read More
Temozolomide-perillyl alcohol conjugate granted FDA orphan status for glioma
Read More